Results 121 to 130 of about 2,368 (193)

Estimating and Projecting Efficacy of Monoclonal Antibodies Against Respiratory Syncytial Virus Beyond Clinical Trial Periods. [PDF]

Vaccines (Basel)
Wang D, Lang JC, Kura K, Chen YH.
europepmc   +1 more source

Detection of nirsevimab-resistant RSV-B variants in children carrying the F:N201T substitution through genomic surveillance, Spain, 2025/26 season. [PDF]

Euro Surveill
Iglesias-Caballero M, Infantes JA, Campoy A, Camarero-Serrano S, Moreno S, Cano O, Vallejo-Palma G, González-Velasco C, Gaona C, Camacho-Martinez P, Merino-Diaz L, Vázquez-Morón S, Pozo F, Lepe JA, Mas V, Casas I.   +15 more
europepmc   +1 more source

Acute viral bronchiolitis before and after implementation of <i>nirsevimab</i> prophylaxis in Italy: a multicentre retrospective cohort study. [PDF]

Lancet Reg Health Eur
Spatuzzo M, Corsello A, Riccò M, Bonci E, Di Francesco D, Strati MF, Amodio G, Manzalini R, Costantini E, Mazzotti S, Renni M, Coralluzzo F, Langone L, Fiumicelli E, Albonico G, Adornato S, Passarella V, Piras A, Forcucci F, Capuano MC, Basile A, Albini M, Cafforio A, Coppola C, Palmoni M, Bertolucci G, Bertolo S, Di Febo C, Donato A, Di Pasquale G, Toscano F, Tolfa G, Arpinelli M, Marseglia GL, Agostiniani R, Midulla F, ONSP-RSV Study Group.   +36 more
europepmc   +1 more source

Pediatricians' attitudes and knowledge of RSV immunization products: A multi-country cross-sectional survey. [PDF]

PLoS One
Di Chiara C, Piché-Renaud PP, Rigamonti V, Cantarutti A, Calvo C, Rivero Calle I, Soriano-Arandes A, Giaquinto C, Cantarutti L, Donà D, Lo Vecchio A, Hadjipanayis A, Pana ZD, Kopsidas I, Rose A, Tagarro A, Morris SK.   +16 more
europepmc   +1 more source

Respiratory Syncytial Virus-Related Hospitalizations Among Infants Receiving Nirsevimab.

JAMA Netw Open
Buchan SA, Xie J, Bhatt M, Papenburg J, Goldfarb DM, Pernica JM, Burstein B, Gravel J, Berthelot S, Kam AJ, Poonai N, Eltorki M, Finkelstein Y, Sabhaney V, Cheng J, Gill PJ, Dickinson JA, Kwong JC, Freedman SB, SPRINT-KIDS Project Team.   +19 more
europepmc   +1 more source

Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network. [PDF]

Lancet Reg Health West Pac
Wadia U, Richmond PC, Britton PN, Carr J, Clark JE, Crawford NW, Hung TY, Marshall HS, Macartney KK, Wood NJ, McMullan BJ, Moore HC, Effler PV, Cheng AC, Blyth CC, PAEDS-FluCAN Network.   +15 more
europepmc   +1 more source

Maternal Immunization Against Respiratory Syncytial Virus: An Updated WAidid Consensus Document on Evidence, Implementation, and Public Health Priorities. [PDF]

Vaccines (Basel)
Esposito S, Riccò M, Abu-Raya B, Icardi G, Spoulou V, Greenberg D, Falup Pecurariu O, Hung IF, Osterhaus A, Sambri V, Principi N.   +10 more
europepmc   +1 more source

Analysis of the Economic and Public Health Impact of New Immunization Strategies in Infants Against Respiratory Syncytial Virus (RSV) in Colombia. [PDF]

Infect Dis Ther
Carrasquilla-Sotomayor M, Alvis-Zakzuk NJ, Coronell-Rodríguez W, Arias A, Moyano-Tamara L, Alvarado-Gonzalez JC, De la Hoz-Restrepo F, Alvis-Guzman N.   +7 more
europepmc   +1 more source

Acute Respiratory Infections in Children: A Narrative Perspective on Integrated Primary-Hospital Care in Italy. [PDF]

Children (Basel)
Indolfi C, Klain A, Dinardo G, Grella C, Cascone S, Miraglia Del Giudice M.   +5 more
europepmc   +1 more source

Impact of Universal Nirsevimab Immunoprophylaxis on RSV-Related Hospitalizations in Infants: A Two-Season Multicenter Study in Northern Italy. [PDF]

Pathogens
Gianotto NR, Ragusa N, Deut V, Mattivi C, Cherubini Scarafoni M, Dominici S, Mazzetti G, Sandei M, Lo Presti C, Manuela C, Calvo MM, Berger M.   +11 more
europepmc   +1 more source